ctDNA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ctDNA
Jul 19, 2024, 13:56 |
Blog
Bishoy M. Faltas: Grateful for the 2024 Bladder Cancer Advocacy Network Innovation Award!
Dr. Bishoy M. Faltas, Chief Research Officer at Englander Institute For Precision Medicine at Weill…
Jul 18, 2024, 09:57 |
Blog
Chinmay Jani: Our project on ctDNA in RCC through Tempus database presented at KCRS24
Chinmay Jani, Clinical Fellow, Hematology and Oncology at the University of Miami, shared a post…
Jul 18, 2024, 09:35 |
Insight
ctDNA variant-specific differences as potential mPDAC prognostic biomarker - PICI
Parker Institute for Cancer Immunotherapy (PICI) shared a post on X about a recent paper titled…
Jul 16, 2024, 20:13 |
Insight
Chinmay Jani: Truly honored to receive the Merit Award
Chinmay Jani, Clinical Fellow, Hematology and Oncology at University of Miami, made the following post…
Jul 16, 2024, 13:20 |
Blog
Mya Tran: Another year of many developments in precision medicine
Mya Tran, Thoracic Clinical Pharmacist, PharmD, BCOP, at Indiana University Health - Simon Comprehensive Cancer Center,…
Jul 13, 2024, 11:17 |
Blog
David Planchard: New option in the 1st line strategy for NSCLC EGFRmut patients
David Planchard, Thoracic Oncologist at Gustave Roussy, shared on LinkedIn: "Great news, a new option…
Jul 12, 2024, 23:29 |
Insight
Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC
Biagio Ricciuti shared on X: "Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC…
Jul 7, 2024, 17:43 |
Insight
Jarushka Naidoo: ctDNA+ associates with outcomes in stage III unresectable NSCLC
Jarushka Naidoo shared a post on X: “ctDNA+ in consolidation IO trial (BTCRC 16-081) associates…
Jul 7, 2024, 07:04 |
Blog
Stephen V. Liu: Can we use ctDNA to personalize use of consolidation immunotherapy after chemoradiation?
Stephen V. Liu shared on X: “Can we use ctDNA to personalize use of consolidation…
Jul 6, 2024, 13:16 |
Blog
Wafik El-Deiry about DAVA Oncology 3rd Global Thoracic Malignancies Summit
Wafik El-Deiry shared posts on LinkedIn and X: . "Grateful for opportunity to speak about…
Jul 1, 2024, 17:09 |
Blog
Patrick Hwu: ctDNA testing, cancer screening and treatment
Patrick Hwu shared a post LinkedIn: “How are we using ctDNA testing, also called liquid…
Jun 28, 2024, 13:15 |
Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 11:08 |
Insight
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results Authors: E. Felip, B.C.…
Jun 27, 2024, 02:31 |
Blog
Yüksel Ürün: Proud mentor moment
Yüksel Ürün shared a post on X: “Proud mentor moment! Congratulations Emre for the speech…
Jun 26, 2024, 07:54 |
Insight
Importance of ctDNA turn around
Aparna Parikh shared on X: "More on adjuvant timing. Will be interesting to see surveillance ctDNA…
Jun 26, 2024, 03:57 |
Insight
George Laliotis: Peri-operative FOLFIRINOX improved outcomes in patients with pancreatic cancer
George Laliotis, Translational Medicine Lead of GU Oncologist at Natera, shared a post by JAMA…
Jun 24, 2024, 22:56 |
Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 24, 2024, 04:23 |
Blog
Arturo LoAIza-Bonilla: One of the highest TMBs I have seen
Arturo LoAIza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio, shared a post on LinkedIn: .…
Jun 22, 2024, 11:50 |
Insight
Mark Gardner: The 5 year results from the DYNAMIC trial were shared at ASCO
Mark Gardner, SVP Genomic Medicine and Oncology at Quest Diagnostics, shared on LinkedIn: "In case you…
Jun 21, 2024, 11:04 |
Insight
Niklas Klümper: CtDNA will play an important role for tailoring treatment of MIBC
Niklas Klümper, Resident in Urology and Researcher at the Institute for Experimental Oncology at the…
Jun 10, 2024, 07:18 |
Blog
Francisco J. Esteva: Emerging technologies are set to revolutionize the detection and application of biomarkers in cancer treatment
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 4, 2024, 11:51 |
Blog
Pashtoon Kasi: Remember to come to Liquid Biopsies ctDNA session that I’m delighted to chair
Pashtoon Kasi shared on LinkedIn: "Remember to come to this session today that I’m delighted to…
Jun 3, 2024, 21:15 |
Societies
Pashtoon Kasi: Let’s talk about Liquid Biopsies
Pashtoon Kasi recently shared on LinkedIn: "Let’s talk about Liquid Biopsies. Discussion beyond colorectal cancer…
Jun 1, 2024, 00:10 |
Insight
Margaret Gatti-Mays: My top 10 list of abstracts for breast cancer
Margaret Gatti-Mays, Co-Director of the Division of Medical Oncology at the Ohio State University, shared on…
May 29, 2024, 12:03 |
Insight
Eric Singhi: MARIPOSA a path forward to help us determine who benefits from 1L combination therapy?
Eric Singhi shared on X: "MARIPOSA: Amivantamab + lazertinib v osimertinib in 1L EGFR+ mNSCLC:…
May 28, 2024, 11:14 |
Societies
Shaalan Beg and Mohamed E. Salem discuss emerging CART-cell approaches in GI cancers - ASCO
ASCO recently shared a post on X: "Shaalan Beg of Science 37 and Mohamed E.…
May 27, 2024, 05:34 |
Opinion
Tom Powles: The ASCO 24 highlight In My Opinion
Tom Powles, Director of Barts Cancer Center, shared on X: “The ASCO 24 highlight IMO. Currently…
May 26, 2024, 12:09 |
Societies
Nakul Shah: If you are at ASCO24 be sure to check out some amazing research on ctDNA by Michael La Pelusa
Nakul Shah, Oncology Fellow at MD Anderson Cancer Centre, shared on X: "If you are…
May 23, 2024, 17:31 |
Insight
Umberto Malapelle: Proud to share a big team effort on non-small cell lung cancer
Umberto Malapelle, Chief of Predictive Molecular Pathology Laboratory at University Federico II of Naples, shared…
May 19, 2024, 02:10 |
Societies
Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making
Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: . "At…
May 16, 2024, 09:09 |
Blog
Kohei Shitara: Happy to report biomarkers in DESTINIY GC01 at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan shared a post on X:…
May 8, 2024, 08:49 |
Blog
Pashtoon Kasi: A huge step to be able to see ctDNA results realtime/easy access
Pashtoon Kasi shared a post on X: "As of April 2024, our liquid biopsy ctDNA…
May 8, 2024, 00:09 |
Blog
Bishal Gyawali: My journal club on DYNAMIC trial study
Bishal Gyawali, Associate Professor in Medical Oncology and Public Health Sciences in the Division of…
May 6, 2024, 20:08 |
Insight
Sergio Cifuentes: ctDNA for predicting response and prognosis in HER2-BC in NAC
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X/Twitter: "ctDNA for predicting response and…
Apr 16, 2024, 01:48 |
Drugs
Paolo Ciracì: Liquid biopsy to guide adjuvant treatment choice in CRC
Paolo Ciracì, Oncology Resident at University Hospital of Pisa, shared on X/Twitter: "Liquid biopsy to…
Apr 8, 2024, 22:27 |
Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions Authors: Charbel Hobeika,…
Apr 2, 2024, 21:57 |
Blog
Pashtoon Kasi: Was a delight to be on The Late Night Oncology Show
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, shared a post by Erick…
Mar 20, 2024, 15:08 |
Opinion
Herbert Loong: I am adopting the use of ctDNA more and more in my GIST practice
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong shared a post…
Mar 16, 2024, 20:23 |
Insight
Pashtoon Kasi: ctDNA is here to stay
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on LinkedIn: "Just…
Mar 15, 2024, 15:38 |
Blog
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 14, 2024, 19:28 |
Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Mar 13, 2024, 23:46 |
Blog
Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on LinkedIn: “Our meta-analysis looking…
Mar 3, 2024, 17:30 |
Insight
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn: "I want to…
Feb 23, 2024, 11:21 |
Insight
Shilpa Gupta: We report for the 1st time the role of tumor fraction in ctDNA in patients with metastatic urothelial cancer in real world
Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared on X/Twitter: "We report…
Feb 22, 2024, 17:59 |
Blog
“The Immuno-Oncology Curve” with Dr. Steven O'Day – Guests are Dr. Joseph Grossman and Dr. Benny Johnson
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "In the latest episode…
Feb 15, 2024, 11:05 |
Blog
Kohei Shitara: Happy to report ctDNA analysis of PARADIGM at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan, shared a post on…
Feb 10, 2024, 15:34 |
Insight
Alessandro Russo: Our editorial on the potential role of ctDNA in resectable NSCLC undergoing neo-adj chemo
Alessandro Russo, Medical Oncologist at A.O. Papardo, Messina, recently shared the following insight on X/Twitter:…
Jan 21, 2024, 05:16 |
Insight
Yüksel Ürün: ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients
Yüksel Ürün, Professor of Medical Oncology at AnkaraUniversity, shared the photo of Pashtoon Kasi on…
Dec 8, 2023, 17:40 |
Insight
Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
Ibrahim Halil Sahin, GI Medical Oncologist at UPMC, shared on X/Twitter: "A common question I…
Dec 2, 2023, 15:23 |
Blog
Yüksel Ürün: The ctDNA clearance during definitive SOC therapy is associated with improved outcome
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: "A study shows combining circulating…
Nov 15, 2023, 17:25 |
Societies
We are proud to collaborate with MENARINI Group and Natera Oncology on EORTC 2129-BCG TREAT ctDNA - EORTC
EORTC - European Organization for Research and Treatment of Cancer shared Natera Oncology's post on LinkedIn…
Oct 26, 2023, 09:27 |
Opinion
Maurizio Scaltriti: What stands out at ESMO23 is the critical role that innovative trial design, early mechanistic studies and ongoing translational analysis play in informing treatment strategy
Oct 11, 2023, 21:48 |
Blog
Elsa Anagnostou: Pleased to see stage 1 of our ctDNA molecular response adaptive clinical trial in print.
Elsa Anagnostou, Director of Thoracic Oncology Biorepository and Associate Professor of Oncology at Johns Hopkins…
Jul 18, 2023, 18:50 |
Blog
Excellent summary of the progress being made for use of ctDNA in developing new cancer treatments - Jeff Allen
Excellent summary of our recent project results and the progress being made for use of…
Jul 12, 2023, 19:33 |
Insight
ctDNA will enable earlier detection and tailored treatment modifications to improve patient outcomes - Diana Merino Vega
Thanks Friends of Cancer Research and my fellow panelists for a great discussion on the importance of…
All:
55
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube